Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.

@article{Altun2009NephrogenicSF,
  title={Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.},
  author={Ersan Altun and Diego R. Mart{\'i}n and Rebecca Wertman and Caroline Ziemer and Edwin Robert Fuller and R C Semelka},
  journal={Radiology},
  year={2009},
  volume={253 3},
  pages={
          689-96
        }
}
PURPOSE To determine the incidence of nephrogenic systemic fibrosis (NSF) in tertiary care centers of two U.S. universities following the switch from the use of gadodiamide to gadobenate dimeglumine and gadopentetate dimeglumine, and the adoption of restrictive gadolinium-based contrast agent (GBCA) policies. MATERIALS AND METHODS Institutional review board approval with waiver of informed consent was obtained for this Health Insurance Portability and Accountability Act-compliant… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 50 CITATIONS, ESTIMATED 26% COVERAGE

FILTER CITATIONS BY YEAR

2008
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations